146 related articles for article (PubMed ID: 37366248)
1. A novel adenosine signalling-based prognostic signature in gastric cancer and its association with cancer immune features and immunotherapy response.
Yu Y; Wang Y; Xi D; Wang N; Gao L; Shi Q; Yu R; Li H; Xiang L; Maswikiti EP; Chen H
Cell Biol Int; 2023 Sep; 47(9):1650-1664. PubMed ID: 37366248
[TBL] [Abstract][Full Text] [Related]
2. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
3. Integrated analysis of single-cell and bulk RNA-sequencing reveals a novel signature based on NK cell marker genes to predict prognosis and immunotherapy response in gastric cancer.
Sun JR; Kong CF; Ye YX; Wang Q; Qu XK; Jia LQ; Wu S
Sci Rep; 2024 Apr; 14(1):7648. PubMed ID: 38561388
[TBL] [Abstract][Full Text] [Related]
4. A Novel Glycolysis-Related Long Noncoding RNA Signature for Predicting Overall Survival in Gastric Cancer.
Zeng J; Li M; Dai K; Zuo B; Guo J; Zang L
Pathol Oncol Res; 2022; 28():1610643. PubMed ID: 36419649
[No Abstract] [Full Text] [Related]
5. Combining single-cell sequencing data to construct a prognostic signature to predict survival, immune microenvironment, and immunotherapy response in gastric cancer patients.
Hu B; Meng Y; Qu C; Wang BY; Xiu DR
Front Immunol; 2022; 13():1018413. PubMed ID: 36300104
[TBL] [Abstract][Full Text] [Related]
6. A new risk model based on a 11-m
Lei L; Li N; Yuan P; Liu D
BMC Cancer; 2022 Apr; 22(1):365. PubMed ID: 35382776
[TBL] [Abstract][Full Text] [Related]
7. HIPPO signaling-related signature for predicting prognosis and therapeutic response in gastric cancer.
Jiang R; Wang J; Liang J; Lin D; Mao Q; Cheng S; Huang S; Tong S; Lyu Y; Wei R; Lian Q; Chen H
Front Pharmacol; 2022; 13():1096055. PubMed ID: 36712672
[No Abstract] [Full Text] [Related]
8. A signature of 14 immune-related gene pairs predicts overall survival in gastric cancer.
Zhao E; Zhou C; Chen S
Clin Transl Oncol; 2021 Feb; 23(2):265-274. PubMed ID: 32519178
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
10. Identification of an EMT-Related Gene Signature for Predicting Overall Survival in Gastric Cancer.
Dai W; Xiao Y; Tang W; Li J; Hong L; Zhang J; Pei M; Lin J; Liu S; Wu X; Xiang L; Wang J
Front Genet; 2021; 12():661306. PubMed ID: 34249086
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of a 14 immune-related gene pair signature to predict the prognosis and immune features of gastric cancer.
Liu C; Chen B; Huang Z; Hu C; Jiang L; Zhao C
Int Immunopharmacol; 2020 Dec; 89(Pt B):107074. PubMed ID: 33049494
[TBL] [Abstract][Full Text] [Related]
12. Construction of ovarian metastasis-related immune signature predicting prognosis of gastric cancer patients.
Gao J; Huo S; Zhang Y; Zhao Z; Pan H; Liu X
Cancer Med; 2023 Jan; 12(1):913-929. PubMed ID: 35621244
[TBL] [Abstract][Full Text] [Related]
13. A signature of 24 aging‑related gene pairs predict overall survival in gastric cancer.
Zhang Y; Yan Y; Ning N; Shen Z; Ye Y
Biomed Eng Online; 2021 Apr; 20(1):35. PubMed ID: 33823856
[TBL] [Abstract][Full Text] [Related]
14. Identification of a Four-Gene-Based SERM Signature for Prognostic and Drug Sensitivity Prediction in Gastric Cancer.
Jia X; Chen B; Li Z; Huang S; Chen S; Zhou R; Feng W; Zhu H; Zhu X
Front Oncol; 2021; 11():799223. PubMed ID: 35096599
[TBL] [Abstract][Full Text] [Related]
15. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma.
Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X
Front Oncol; 2023; 13():1182434. PubMed ID: 37346073
[TBL] [Abstract][Full Text] [Related]
16. Development and Verification of an Immune-Based Gene Signature for Risk Stratification and Immunotherapeutic Efficacy Assessment in Gastric Cancer.
Qiu F; Zhu Y; Shi Y; Ji J; Jin Y
Dis Markers; 2021; 2021():4251763. PubMed ID: 34804261
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide identification of CpG island methylator phenotype related gene signature as a novel prognostic biomarker of gastric cancer.
Zeng Z; Xie D; Gong J
PeerJ; 2020; 8():e9624. PubMed ID: 32821544
[TBL] [Abstract][Full Text] [Related]
18. Association of genes in hereditary metabolic diseases with diagnosis, prognosis, and treatment outcomes in gastric cancer.
Li Y; Li X; Yang Y; Qiao X; Tao Q; Peng C; Han M; Dong K; Xu M; Wang D; Han G
Front Immunol; 2023; 14():1289700. PubMed ID: 38022516
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel m6A-related lncRNA pair signature for predicting the prognosis of gastric cancer patients.
Wang JM; Li X; Yang P; Geng WB; Wang XY
BMC Gastroenterol; 2022 Feb; 22(1):76. PubMed ID: 35189810
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Characterization of RNA Processing Factors in Gastric Cancer Identifies a Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses.
Lou S; Meng F; Yin X; Zhang Y; Han B; Xue Y
Front Immunol; 2021; 12():719628. PubMed ID: 34413861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]